Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Burdock Root

Plans To Improve Access To Occupational Health Services In Wales Announced
Plans to improve access to occupational health services in Wales to help tackle absenteeism and ill-health in the workplace will be announced today [Tuesday, 14 July] by Health Minister Edwina Hart.
generic viagra online
Maternal Immunity Not All Good For A Fetus
As a fetus does not mount an immune response to maternal proteins that cross the placenta, it has been assumed that a fetus would not reject non-genetically matched blood cells (specifically allogeneic blood cells) if they were transplanted while the fetus was in utero. The hope is that this procedure, which is known as IUHCT, could provide a viable approach for treating congenital blood disorders. However, studies using a mouse model of IUHCT indicate that most fetal recipients of allogeneic blood cells lose their transplanted cells 3-5 weeks after transplantation. Alan Flake and colleagues, at Children"s Hospital of Philadelphia, have now identified an immune mechanism responsible for graft failure in this model of IUHCT. Surprisingly, although fetal immune cells eliminated the transplanted allogeneic blood cells, they were triggered to do so by immune molecules known as alloantibodies that they obtained from their mother"s breast milk. The maternal alloantibodies were produced in response to IUHCT and so the authors conclude that in the absence of either a maternal immune response or transmission of the maternal alloantibodies to the fetus, transplanted blood cells should not be rejected, leaving open the door for IUHCT as a potential clinical strategy.
News of the day
Animal-based Research Key To Medicine Safety
The innovative pharmaceutical industry is committed to ensuring any animal-based
Endocrinology

TREAT TB Web Portal Launched

The Union-managed initiative TREAT TB (Technology, Research, Education and Technical Assistance for TB) is now on the web offering direct access to the work of this five-year, USAID-funded project. The new Union-managed initiative TREAT TB (Technology, Research, Education and Technical Assistance for TB) now has a web portal. You can go directly to http://www.treattb.org or access the portal via the Tuberculosis Department web site to learn more about this 5-year, USAID-funded project. The goals of TREAT TB are to contribute to new knowledge through field evaluations of diagnostic tools, clinical trials of priority research questions, and targeted operational research benefitting global regional and country TB control efforts. Using the web portal, you will be able to: - Stay up-to-date on important news about TREAT TB - Learn more about TREAT TB partners - Get the latest TB-related news from around the world - Download documents about TREAT TB and its activities TREAT TB is managed by The Union North America Office in New York. For more information, please visit http://www.treattb.org, call +1 212 500 5720, or email Bruno Bui, Project Administrator, at bbui@theunion.org . TREAT TB


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009